Opportunity Information: Apply for CDC RFA GH15 1589
Apply for CDC RFA GH15 1589
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Improving Evaluation Capacity within the Government of Tanzania under the Presidents Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067 Global AIDS.
- This funding opportunity was created on Jan 23, 2015 and posted on Dec 1, 2014.
- Applicants must submit their applications by Jan 26, 2015 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $3,500,000.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $3,500,000.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Tanzania National Institute of Medical Research (NIMR)
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity "Improving Evaluation Capacity within the Government of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)" is a CDC-funded cooperative agreement designed to strengthen Tanzania's ability to generate, manage, and use high-quality evidence for HIV and broader public health decision-making. The award focuses on building durable evaluation, research, laboratory quality, and data systems capacity within the Tanzania National Institute for Medical Research (NIMR), with the broader goal of improving the credibility and policy impact of research and strengthening the country's readiness to detect and respond to disease outbreaks. Because it is structured as a cooperative agreement, the CDC is expected to remain actively involved with the recipient through ongoing technical collaboration rather than operating as a hands-off funder.
At the core of the approach is targeted institutional capacity building, combining hands-on mentoring, formal training, and routine technical coordination to improve how research is designed, reviewed, implemented, and translated into action. A major component is coaching and mentoring support from RTI to NIMR's Health Systems Strengthening (HSS) research team. This is intended to raise day-to-day research performance through practical guidance on methods, operations, and quality standards, not just one-time workshops. Alongside mentoring, the opportunity emphasizes collaborative protocol development so that NIMR and partners can produce clear, scientifically credible, relevant, and feasible research protocols that can be executed within real-world constraints and still meet international standards.
The activities laid out in the announcement show a strong emphasis on improving research governance and ethical review processes, which are essential for credible evaluation and timely evidence generation. NIMR is expected to hold routine technical meetings with CDC to work through issues related to research databases, protocol development, and ethics clearance. This regular cadence is meant to reduce bottlenecks that often slow research and evaluation, while improving consistency, documentation, and quality control. Another key activity is engagement in collaborative meetings with Tanzania's Field Epidemiology and Laboratory Training Program (FELTP), linking NIMR's research capacity with applied epidemiology and outbreak investigation systems. The intended result is a stronger interface between research institutions and frontline public health response capabilities.
Laboratory and quality assurance elements are also included as enabling conditions for credible public health evidence. The opportunity highlights the need for proper laboratory maintenance agreements, appropriate analysis and storage of samples, and an improved working environment for the National Health Laboratory Quality Assurance and Training Centre (NHLQATC) so it can carry out its core functions reliably. These elements matter because evaluation capacity is not only about statistics and reports; it also depends on dependable specimen handling, testing quality, and laboratory systems that produce trustworthy data for surveillance, research, and program monitoring.
A major data-system component involves strengthening the Master Facility List (MFL) and expanding the use of Geographic Information Systems (GIS) for planning and equity-focused decision-making. NIMR is expected to develop standards for the MFL system and to continuously update and validate the MFL database so that facility information is accurate, consistent, and usable for program management. Building on that foundation, NIMR is tasked with empowering councils to use GIS as a practical planning tool and providing technical assistance to the Ministry of Health and Social Welfare (MOHSW), vertical programs, and districts on GIS use. The goal is to enable more sophisticated mapping of service coverage and disparities, so policymakers and implementers can identify gaps, target resources, and track progress in prevention and disease management.
The opportunity describes outcomes across short-, intermediate-, and long-term horizons. In the short term (roughly 1 to 2 years), the emphasis is on putting basic systems and supports in place: laboratory maintenance agreements are established, samples are correctly analyzed and stored, and the NHLQATC working environment is improved so core functions can be performed consistently. On the research side, early gains are expected in practical skills and process improvements, including stronger ability to engage in and conduct quality research, better dissemination of findings in a timely way, and more systematized and thorough ethical review processes. These near-term changes are designed to reduce common barriers like unclear protocols, slow approvals, and weak documentation, all of which undermine evaluation quality and usefulness.
In the intermediate term (about 3 to 4 years), the grant aims to translate these foundational improvements into stronger operational performance and greater responsiveness to public health threats. With sustained training, mentoring, and coordination with CDC and FELTP, NIMR is expected to improve its ability to communicate during and support outbreak investigations, which contributes to earlier detection and faster response. At the same time, the MFL and GIS work should mature into more proficient, routine use of geospatial information to document disparities and inform program and policy development. This period is essentially about moving from capacity "inputs" (training, meetings, standards) to capacity "outputs" (better investigations, better planning tools, better applied analytics used by councils and programs).
In the long term (around 5 years), the desired outcome is an enhanced research and investigative capacity at NIMR that produces credible, policy-relevant evidence with real impact on practice. The announcement explicitly points to improved delivery of credible research that influences policies and programs, which is the ultimate test of evaluation capacity: not simply producing studies, but producing findings that decision-makers trust and can use. By strengthening ethical review systems, research protocol quality, laboratory support functions, outbreak-related collaboration, and national facility and GIS data systems, the grant is designed to leave behind lasting institutional capabilities rather than short-lived project outputs.
Administratively, this opportunity was posted by the Centers for Disease Control and Prevention under Funding Opportunity Number CDC RFA GH15-1589, within the health category and tied to CFDA 93.067 (Global AIDS). It anticipated a single award with an estimated total funding amount of $3,500,000, with an award ceiling of $3,500,000 and a floor of $700,000, and no cost-sharing requirement. Eligibility was limited to the Tanzania National Institute for Medical Research (NIMR), reflecting the intent to directly strengthen government-affiliated national research capacity. The announcement was originally posted in December 2014, with the application due date in January 2015, and it was later archived in February 2015. For applicants needing access support at the time, the CDC Procurement and Grants Office contact information was provided (pgotim@cdc.gov; 770-488-2700).
Frequently Asked Questions (FAQs)
What is the name of this grant opportunity?
The opportunity is titled "Improving Evaluation Capacity within the Government of Tanzania under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which U.S. government agency is funding this opportunity?
The opportunity was posted by the Centers for Disease Control and Prevention (CDC).
What type of funding mechanism is being used?
This is a cooperative agreement, which means CDC is expected to remain actively involved with the recipient through ongoing technical collaboration rather than acting as a hands-off funder.
What is the main purpose of the award?
The award is designed to strengthen Tanzania's ability to generate, manage, and use high-quality evidence for HIV and broader public health decision-making.
Which institution is the primary focus of capacity building?
The award focuses on building durable evaluation, research, laboratory quality, and data systems capacity within the Tanzania National Institute for Medical Research (NIMR).
How does this opportunity connect to PEPFAR?
It is framed under PEPFAR and is tied administratively to CFDA 93.067 (Global AIDS), while also aiming to strengthen broader public health evidence and outbreak readiness.
Why is the award described as strengthening "evaluation capacity" rather than only funding research studies?
The emphasis is on lasting institutional capabilities, such as research governance, ethical review systems, laboratory quality assurance, outbreak-linked collaboration, and national data systems (like the Master Facility List and GIS), rather than short-lived project outputs.
What role is CDC expected to play during implementation?
CDC is expected to stay actively engaged through routine technical coordination and collaboration, including regular meetings to address issues related to research databases, protocol development, and ethics clearance.
What kinds of capacity-building activities are emphasized?
The approach combines hands-on mentoring, formal training, and routine technical coordination to improve how research is designed, reviewed, implemented, and translated into action.
Is mentoring a one-time training event under this award?
No. The description emphasizes practical, ongoing coaching and mentoring aimed at improving day-to-day research performance, not just standalone workshops.
Who is providing coaching and mentoring support to NIMR according to the description?
Coaching and mentoring support is described as coming from RTI to NIMR's Health Systems Strengthening (HSS) research team.
What is meant by "collaborative protocol development" in this opportunity?
It refers to working jointly so that NIMR and partners produce clear, scientifically credible, relevant, and feasible research protocols that can be implemented within real-world constraints while meeting international standards.
What governance or ethics-related improvements are expected?
The opportunity emphasizes strengthening research governance and ethical review processes, including more systematized and thorough ethical review and routine technical engagement to help reduce bottlenecks that delay research and evaluation.
How are routine technical meetings expected to help?
Regular meetings with CDC are intended to work through issues related to research databases, protocol development, and ethics clearance, reducing common bottlenecks while improving consistency, documentation, and quality control.
How does the opportunity link research capacity to outbreak response?
It includes engagement in collaborative meetings with Tanzania's Field Epidemiology and Laboratory Training Program (FELTP), aiming to strengthen the interface between research institutions and frontline public health response capabilities.
What laboratory-related activities are included and why do they matter?
The opportunity highlights laboratory maintenance agreements, appropriate analysis and storage of samples, and improving the working environment for the National Health Laboratory Quality Assurance and Training Centre (NHLQATC). These are positioned as enabling conditions for trustworthy public health evidence because reliable specimen handling and testing quality support credible surveillance, research, and program monitoring data.
What is the NHLQATC and what is expected for it under the award?
The NHLQATC is the National Health Laboratory Quality Assurance and Training Centre. The award describes improving its working environment so it can carry out core functions reliably and consistently.
What is the Master Facility List (MFL) work described in the announcement?
NIMR is expected to develop standards for the MFL system and continuously update and validate the MFL database so facility information is accurate, consistent, and usable for program management.
What is the role of Geographic Information Systems (GIS) in this opportunity?
GIS is positioned as a practical planning and equity-focused decision-making tool. The opportunity describes empowering councils to use GIS for planning and providing technical assistance to the Ministry of Health and Social Welfare (MOHSW), vertical programs, and districts on GIS use to better map service coverage and disparities.
Which government bodies are expected to receive GIS-related technical assistance?
The announcement describes technical assistance for the Ministry of Health and Social Welfare (MOHSW), vertical programs, and districts, along with empowering councils to use GIS as a planning tool.
What short-term outcomes are expected (about 1 to 2 years)?
Short-term outcomes include establishing laboratory maintenance agreements, ensuring samples are correctly analyzed and stored, improving the NHLQATC working environment, strengthening practical research skills and processes, improving timely dissemination of findings, and making ethical review processes more systematized and thorough.
What intermediate outcomes are expected (about 3 to 4 years)?
Intermediate outcomes include improved communication during and support for outbreak investigations (supporting earlier detection and faster response) and more proficient, routine use of MFL and GIS to document disparities and inform program and policy development.
What long-term outcomes are expected (around 5 years)?
The long-term outcome is enhanced research and investigative capacity at NIMR that produces credible, policy-relevant evidence that influences policies and programs, supported by stronger ethical review, protocol quality, laboratory support functions, outbreak collaboration, and national facility and GIS data systems.
How much funding was anticipated under this announcement?
The estimated total funding amount was $3,500,000.
What were the award ceiling and floor?
The award ceiling was $3,500,000 and the floor was $700,000.
Was cost sharing or matching required?
No cost-sharing requirement was stated for this opportunity.
How many awards were anticipated?
The announcement anticipated a single award.
Who was eligible to apply?
Eligibility was limited to the Tanzania National Institute for Medical Research (NIMR), reflecting an intent to directly strengthen government-affiliated national research capacity.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH15-1589.
What CFDA number is associated with this opportunity?
The opportunity is tied to CFDA 93.067 (Global AIDS).
When was the opportunity posted, due, and archived?
The announcement was originally posted in December 2014, the application due date was in January 2015, and it was later archived in February 2015.
Who could applicants contact for access support?
The CDC Procurement and Grants Office contact information provided was pgotim@cdc.gov and 770-488-2700.
Does the archived status affect whether it is currently open for applications?
The announcement is described as archived (February 2015), which indicates it is not presented here as a currently open application opportunity.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Partnering with Pasteur Institute of Ho Chi Minh City to Enhance Regional Capacity to Prevent, Detect, Monitor, and Respond to the HIV/AIDS Epidemic in Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR)
Previous opportunity: Shenandoah Valley Battlefields National Historic District
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH15 1589
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH15 1589) also looked into and applied for these:
| Funding Opportunity |
|---|
| Partnering with Pasteur Institute of Ho Chi Minh City to Enhance Regional Capacity to Prevent, Detect, Monitor, and Respond to the HIV/AIDS Epidemic in Vietnam under the Presidents Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH15 1595 Funding Number: CDC RFA GH15 1595 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $4,000,000 |
| Statewide Family Network Program Apply for SM 15 001 Funding Number: SM 15 001 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $95,000 |
| Statewide Consumer Network Program Apply for SM 15 002 Funding Number: SM 15 002 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $95,000 |
| Service Area Competition Additional Areas (SAC AA) Green Valley, AZ Wichita, KS Franklin, NH Washington, NC and Cheyenne, WY Apply for HRSA 15 139 Funding Number: HRSA 15 139 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator Directed Therapeutics (R41) Apply for RFA HL 15 026 Funding Number: RFA HL 15 026 Agency: National Institutes of Health Category: Health Funding Amount: $350,000 |
| Human Cellular Models for Predicting Individual Responses to Cystic Fibrosis Transmembrane Conductance Regulator Directed Therapeutics (R43/R44) Apply for RFA HL 15 027 Funding Number: RFA HL 15 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| High Priority Immunology Grants (R01) Apply for PAS 15 055 Funding Number: PAS 15 055 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Perinatal and Infant Oral Health Quality Improvement Expansion Grant Program Apply for HRSA 15 070 Funding Number: HRSA 15 070 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Advanced Nursing Education Program Apply for HRSA 15 046 Funding Number: HRSA 15 046 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R21) Apply for PA 15 057 Funding Number: PA 15 057 Agency: National Institutes of Health Category: Health Funding Amount: $275,000 |
| Unconventional Roles of Ethanol Metabolizing Enzymes, Metabolites, and Cofactors in Health and Disease (R01) Apply for PA 15 058 Funding Number: PA 15 058 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| NIDCR Clinical Trial or Biomarker Clinical Validation Study Cooperative Agreement (U01) Apply for PAR 15 059 Funding Number: PAR 15 059 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Predoctoral Training in General, Pediatric and Public Health Dentistry and Dental Hygiene Apply for HRSA 15 050 Funding Number: HRSA 15 050 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U01) Apply for RFA HL 17 001 Funding Number: RFA HL 17 001 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Epi Centers for the Prevention of Healthcare Associated Infections, Antimicrobial Resistance and Adverse Events A Multicenter Program Expansion (U54) Apply for RFA CK 11 0010501SUPP15 Funding Number: RFA CK 11 0010501SUPP15 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $800,000 |
| Creating Asthma Empowerment Collaborations to Reduce Childhood Asthma Disparities (U34) Apply for RFA HL 15 028 Funding Number: RFA HL 15 028 Agency: National Institutes of Health Category: Health Funding Amount: $225,000 |
| Radiological/Nuclear Medical Countermeasure Product Development Program (R43/R44) Apply for PA 15 065 Funding Number: PA 15 065 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Postdoctoral Training in General, Pediatric, and Public Health Dentistry Apply for HRSA 15 051 Funding Number: HRSA 15 051 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Nurse Anesthetist Traineeship Program (NAT) Apply for HRSA 15 047 Funding Number: HRSA 15 047 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Innovation Grants to Nurture Initial Translational Efforts (IGNITE) Assay Development and Therapeutic Agent Identification and Characterization to Support Therapeutic Discovery (R21/R33) Apply for PAR 15 070 Funding Number: PAR 15 070 Agency: National Institutes of Health Category: Health Funding Amount: $750,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH15 1589", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
